1 / 23

Chapter 5

Chapter 5. Lifespan and Cultural Modifications. Chapter 5 Lesson 5.1. Learning Objectives. Identify specific considerations in administering medications to pediatric, pregnant, breastfeeding, or elderly patients. U.S. Food and Drug Administration (FDA).

josephlwilliams
Download Presentation

Chapter 5

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Chapter 5 Lifespan and Cultural Modifications

  2. Chapter 5 Lesson 5.1

  3. Learning Objectives • Identify specific considerations in administering medications to pediatric, pregnant, breastfeeding, or elderly patients

  4. U.S. Food and Drug Administration (FDA) • Establishes standards that require drug companies to provide consumers with specific drug information • Information printed on product package insert (PPI) • Information includes: • Description of therapeutic response • Side effects • Adverse effects • Possible drug interactions

  5. The Pediatric Patient • Variables have a profound impact on drug action and effect • Neonates (less than 1 month of age) • Small body mass • Low body fat content • High body water volume • Increased membrane permeability

  6. The Pediatric Patient (cont.) • Variables have a profound impact on drug absorption • No gastric acid present at birth • No intestinal bacteria or enzyme function present • Delayed gastrointestinal transit time • Immaturity of liver, kidney, and renal excretion systems

  7. Absorption • Three principles in the pediatric patient • The physiologic status of the infant or child determines the blood flow at the site of intramuscular or subcutaneous drug administration. • Compared with older children and adults, premature infants have immature and unstable body processes. • A newborn’s skin, particularly in premature infants, has a greater ability to absorb some chemicals because of its greater hydration.

  8. Distribution • Two factors • The chemical properties of the drug (do not vary) • The physiologic factors specific to the patient (do vary)

  9. Metabolism • The majority of drug metabolism, or biotransformation, takes place in the liver. • In general, drug metabolism in infants is much slower than that in older children and adults. • Until 3 to 4 years of age, children have the ability to increase production of liver enzymes. • Neonates have a decreased ability to metabolize drugs.

  10. Excretion Renal system may still be immature at birth Decreased glomerular filtration Decreased tubular secretion Decreased tubular reabsorption System still maturing over the first year of life Drug clearance can be compromised

  11. Adverse Drug Reactions • Children are exposed to drugs directly and indirectly. • Transplacentally during pregnancy or delivery • Direct administration • Through ingested breast milk

  12. The Geriatric Patient • React differently to medications than younger adults • Drugs absorbed, metabolized, and excreted more slowly and less completely • Variability in drug response and clearance related to aging organ systems and overall health or illness • Patients age differently; body responses vary

  13. Geriatric Patient Teaching Drug non-adherence related to: • Drug cost • Difficulty obtaining • Diminished cognitive abilities • Lack of desire to take on schedule • Depression • Feelings of being overwhelmed with physical needs • Physical disabilities requiring assistance to administer

  14. Chapter 5 Lesson 5.2

  15. Learning Objectives • Identify specific considerations in administering medications to pediatric, pregnant, breastfeeding, or elderly patients • Identify special considerations for providing care to individuals from different cultures • Describe specific nursing behaviors that assist in helping patients succeed with their medication plans

  16. Medications Used by Women • Females differ from males in hormonal make-up. • Medication needs often related to: • Genital tract infections • Menstruation • Infertility • Pregnancy • Menopause

  17. Medications and Pregnancy • 1961, thalidomide • Teratogenic = likely to cause fetal or embryonic damage or malformations • Few “safe” medications during pregnancy • Weigh benefit of drug for mother against risk to fetus

  18. Medications, Pregnancy, and Breastfeeding • Some medications cross the immature blood-brain barrier of the fetus • Some medications cross the placenta to the fetus • Some medications pass into breast milk to the baby during nursing

  19. Childhood Immunizations • Essential for personal and national protection • Factors related to delay in receiving • Healthcare provider belief of need to delay related to symptoms of mild illness • Parental refusal from concern over adverse effects

  20. Medications Used Throughout the Lifespan • Antidiabetic agents • Antihypertensive agents • Cholesterol-lowering drugs • Smoking-cessation products • Weight-loss drugs • Antidepressant medications • Impotence drugs • Aspirin • Caffeine

  21. Cultural Influences • Cultural assessment includes determining • Values • Religion • Dietary practices • Family lines of authority • Family life patterns • Beliefs and practices related to health and illness

  22. Nursing Assessment of Healthcare Availability • Health disparity • Health literacy

  23. Medication Nonadherence • Six major reasons for client nonadherence • Medications are for prevention • Increases with prolonged therapy • Treatment requires significant changes in behavior • Poor patient understanding • Complexity of treatment plan • Unpleasant side effects

More Related